Matthew Liddelow, Chief Executive Officer at Neuroscientific Biopharmaceuticals Ltd., holds 1.13M shares in Neuroscientific Biopharmaceuticals Ltd. (Ticker: AU:NSB). Most recently, Matthew Liddelow Bought AU$50,000 shares of Neuroscientific Biopharmaceuticals Ltd. on May 18, 2021 for an estimated value of 12.15K.